Rachel M. Mayers

11β-Hydroxysteroid Dehydrogenase Type 1 Regulates Glucocorticoid-Induced Insulin Resistance in Skeletal Muscle

Stuart Morgan, Mark Sherlock, Laura Gathercole et al. · Diabetes · 2009 · 164 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17

Altered Neuropeptide Y Concentrations in Specific Hypothalamic Regions of Obese (<i>fa/fa</i>) Zucker Rats: Possible Relationship to Obesity and Neuroendocrine Disturbances

Pauline E. McKibbin, Stephen J. Cotton, S. McMillan et al. · Diabetes · 1991 · 116 citations

Life Sciences, Endocrinology, Physiology +17

Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats

Victor P. Bilan, Eman Salah, Sheldon Bastacky et al. · Journal of Endocrinology · 2011 · 88 citations · Full text

Medicine, Nephrology, Pharmacology +17

ICI D7114 a novel selective β‐adrenoceptor agonist selectively stimulates brown fat and increases whole‐body oxygen consumption

Brian R. Holloway, Ralph Howe, Balbir S. Rao et al. · British Journal of Pharmacology · 1991 · 82 citations · Full text

Medicine, Pharmacology, Physiology +13

Discovery of a Potent, Selective, and Orally Bioavailable Acidic 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Inhibitor: Discovery of 2-[(3<i>S</i>)-1-[5-(Cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl]-3-piperidyl]acetic Acid (AZD4017)

James S. Scott, Suzanne S. Bowker, Joanne deSchoolmeester et al. · Journal of Medicinal Chemistry · 2012 · 62 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15